Mylan has set its sights on bringing generic versions of three top-selling insulin brands to market. The company has signed a collaboration deal with Biocon to develop and commercialise the Indian ...

Last week, Eli Lilly announced it was introducing a lower-priced authorized generic - a repackaged version of the brand - of its rapidly acting insulin lispro injection (Humalog) in the U.S.. The ...

Mylan has entered into a definitive agreement with Biocon Limited for an exclusive collaboration on the development and commercialization of generic versions of three insulin analog products. Mylan ...

People with diabetes were notified the other day by insurance giant UnitedHealthcare that one of the most widely prescribed insulins, NovoLog, is switching from the company's Tier 1 drug list to Tier ...

WILMINGTON, N.C. (WECT) - A nationwide insulin shortage has been affecting millions of people for over a month now. Companies say they’re getting back on track after some supply chain issues, but some ...